IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness [Yahoo! Finance]
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer [Yahoo! Finance]